ESSA Book Value Per Share from 2010 to 2024

EPIX Stock

USD 1.60 0.01 0.62%

ESSA Pharma Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share will likely drop to 1.78 in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of ESSA Pharma according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

2.81422927

Current Value

1.78459227

Quarterly Volatility

2.27495066

Credit Downgrade

Yuan Drop

Covid

Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 8.2 M, as well as many indicators such as Price To Sales Ratio of 272.8 K, Dividend Yield of 0.0 or PTB Ratio of 49.54. ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.

Check out the analysis of ESSA Pharma Correlation against competitors.

For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.

Latest ESSA Pharma's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of ESSA Pharma over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. ESSA Pharma's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ESSA Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 2.90 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

ESSA Book Value Per Share Regression Statistics

	Arithmetic Mean	2.34
	Geometric Mean	2.19
	Coefficient Of Variation	97.17
	Mean Deviation	1.72
	Median	2.52
	Standard Deviation	2.27
	Sample Variance	5.18
	Range	8.7693
	R-Value	0.36
	Mean Square Error	4.85
	R-Squared	0.13
	Significance	0.19
	Slope	0.18
	Total Sum of Squares	72.46

ESSA Book Value Per Share History

	2023	2.81
	2022	3.3
	2021	3.79
	2020	5.04
	2019	3.53
	2018	5.83
	2017	2.0

Other Fundumenentals of ESSA Pharma

Tangible Book Value Per Share

ESSA Pharma Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Net Tangible Assets	Long Term Debt	Net Receivables	Property Plant Equipment	Net Invested Capital	Net Working Capital	Current Deferred Revenue	Capital Stock
Total Assets		1.0	-0.82	-0.81	0.24	-0.07	1.0	-0.04	0.88	0.9	0.53	-0.13	0.7	0.99	0.99	0.27	0.95
Total Stockholder Equity	1.0		-0.82	-0.81	0.21	-0.12	1.0	-0.05	0.88	0.91	0.51	-0.13	0.69	0.99	0.99	0.27	0.96
Net Debt	-0.82	-0.82		0.79	-0.25	0.01	-0.82	-0.02	-0.86	-0.89	-0.55	0.11	-0.69	-0.86	-0.86	-0.55	-0.82
Retained Earnings	-0.81	-0.81	0.79		-0.38	-0.05	-0.81	-0.06	-0.98	-0.96	-0.65	0.17	-0.53	-0.86	-0.86	-0.66	-0.93
Accounts Payable	0.24	0.21	-0.25	-0.38		0.7	0.24	0.26	0.32	0.27	0.23	0.22	0.46	0.22	0.22	0.32	0.28
Total Liab	-0.07	-0.12	0.01	-0.05	0.7		-0.07	0.22	-0.02	-0.08	0.41	-0.05	0.15	-0.09	-0.09	0.0	-0.1
Total Current Assets	1.0	1.0	-0.82	-0.81	0.24	-0.07		-0.05	0.88	0.9	0.54	-0.13	0.7	0.99	0.99	0.26	0.95
Intangible Assets	-0.04	-0.05	-0.02	-0.06	0.26	0.22	-0.05		0.03	0.01	0.02	0.16	0.03	-0.04	-0.04	0.09	-0.02
Common Stock	0.88	0.88	-0.86	-0.98	0.32	-0.02	0.88	0.03		0.99	0.61	-0.15	0.57	0.93	0.93	0.59	0.97
Net Tangible Assets	0.9	0.91	-0.89	-0.96	0.27	-0.08	0.9	0.01	0.99		0.57	-0.15	0.59	0.95	0.95	0.56	0.97
Long Term Debt	0.53	0.51	-0.55	-0.65	0.23	0.41	0.54	0.02	0.61	0.57		-0.24	0.51	0.56	0.56	0.33	0.54
Net Receivables	-0.13	-0.13	0.11	0.17	0.22	-0.05	-0.13	0.16	-0.15	-0.15	-0.24		0.18	-0.15	-0.15	-0.09	-0.16
Property Plant Equipment	0.7	0.69	-0.69	-0.53	0.46	0.15	0.7	0.03	0.57	0.59	0.51	0.18		0.67	0.67	0.15	0.59
Net Invested Capital	0.99	0.99	-0.86	-0.86	0.22	-0.09	0.99	-0.04	0.93	0.95	0.56	-0.15	0.67		1.0	0.32	0.97
Net Working Capital	0.99	0.99	-0.86	-0.86	0.22	-0.09	0.99	-0.04	0.93	0.95	0.56	-0.15	0.67	1.0		0.32	0.97
Current Deferred Revenue	0.27	0.27	-0.55	-0.66	0.32	0.0	0.26	0.09	0.59	0.56	0.33	-0.09	0.15	0.32	0.32		0.48
Capital Stock	0.95	0.96	-0.82	-0.93	0.28	-0.1	0.95	-0.02	0.97	0.97	0.54	-0.16	0.59	0.97	0.97	0.48

Click cells to compare fundamentals

About ESSA Pharma Financial Statements

ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	2.81	1.78
Tangible Book Value Per Share	2.81	1.17

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for ESSA Stock Analysis

When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC